Investigating how protein levels affect the progression of prion diseases
How Substrate Dosage Drives Prion Disease Kinetics
This study is looking at prion diseases, which are serious brain conditions, to see how changing the levels of a specific protein can affect how quickly the disease gets worse, and it hopes to find new ways to help slow down the illness for people who are affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10990546 on NIH RePORTER |
What this research studies
This research focuses on understanding prion diseases, which are rapidly fatal neurodegenerative conditions caused by misfolded proteins. The study examines how varying levels of the prion protein (PrP) influence the speed of disease progression and survival in animal models. By using antisense oligonucleotides to lower PrP levels, the research aims to explore potential therapeutic strategies that could slow down the disease. The goal is to determine how these interventions can be effectively applied across different species and prion strains, ultimately leading to insights that could benefit human patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with prion diseases or those at risk due to genetic factors.
Not a fit: Patients with prion diseases that are not amenable to treatment or those with advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly extend survival and improve quality of life for patients with prion diseases.
How similar studies have performed: Previous research has shown promise in using similar approaches to target protein levels in neurodegenerative diseases, indicating potential for success in this area.
Where this research is happening
Cambridge, United States
- Broad Institute, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Vallabh, Sonia Minikel — Broad Institute, INC.
- Study coordinator: Vallabh, Sonia Minikel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.